Curis Lifesciences Share Price | Curis Lifesciences Stock Screener
CURIS
Pharmaceuticals
Track Curis Lifesciences share price live with TickJournal's free stock screener.
Check CURIS annual price range for the annual price range and momentum.
Use the Curis Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Curis Lifesciences Market Cap
₹84.08 Cr.
CURIS P/E Ratio (TTM)
15.99
Curis Lifesciences P/B Ratio
2.29
EPS (TTM)
₹10.26
Dividend Yield
-
Debt to Equity
1.48
CURIS 52 Week High
-
Curis Lifesciences 52 Week Low
-
Operating Margin
30.00%
Profit Margin
11.11%
CURIS Revenue (TTM)
₹9.00
EBITDA
₹3.00
Net Income
₹1.00
Total Assets
₹82.00
Total Equity
₹47.00
Curis Lifesciences Share Price Chart
Screen Curis Lifesciences share price with an interactive chart. Analyse CURIS price trends and volatility across different timeframes.
Curis Lifesciences Company Profile - Fundamental Screener
Screen Curis Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CURIS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE1BZN01016
Curis Lifesciences Balance Sheet Screener
Screen CURIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 82 | 43 | 34 | 30 | 27 |
| Current Assets | 69 | 31 | 22 | 17 | 15 |
| Fixed Assets | 12 | 11 | 12 | 12 | 12 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 7 | 9 | 10 | 10 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 47 | 16 | 6 | 0 | -1 |
| Share Capital | 8 | 6 | 1 | 1 | 1 |
| Reserves & Surplus | 39 | 10 | 5 | 0 | -1 |
Curis Lifesciences Income Statement Screener - Profit & Revenue Analysis
Screen Curis Lifesciences income statement and profit fundamentals.
Analyze CURIS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Curis Lifesciences share price evaluation.
| Item | 2024-Jun |
|---|---|
| Revenue | 9 |
| Expenses | 6 |
| EBITDA | 3 |
| Operating Profit % | 30.00% |
| Depreciation | 0 |
| Interest | 0 |
| Profit Before Tax | 2 |
| Tax | 1 |
| Net Profit | 1 |
| EPS | 24.00 |
Curis Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen CURIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -2 | 0 | 3 | 5 |
| Investing Activities | 0 | 0 | -1 | 0 |
| Financing Activities | 2 | 0 | -3 | -5 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
Curis Lifesciences Shareholding Pattern Screener
See Curis Lifesciences shareholding pattern with promoter, FII, and DII holdings.
Check Curis Lifesciences promoter holding and ownership changes for CURIS on TickJournal.
| Item | 2026-Mar | 2025-Jun | 2025-Oct | 2025-Nov | 2024-Dec |
|---|---|---|---|---|---|
| Promoter Holding | 68.03% | 92.68% | 92.68% | 68.03% | 92.68% |
| FII Holding | 1.19% | 0.00% | 0.00% | 2.93% | 0.00% |
| DII Holding | 5.80% | 0.00% | 0.00% | 10.86% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 14.38% | 0.00% | 0.00% | 13.97% | 4.37% |
| Other Holding | 10.60% | 7.32% | 7.32% | 4.20% | 2.95% |
| Shareholder Count | 340 | 35 | 36 | 36 | 27 |
Curis Lifesciences Share Dividend Screener - Share Yield Analysis
Check Curis Lifesciences dividend history with payout and yield data.
View Curis Lifesciences dividend details including ex-dates and amounts for CURIS stock.
Curis Lifesciences Stock Index Membership
See which indices include Curis Lifesciences stock.
Check CURIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Curis Lifesciences Market Events Screener - Corporate Actions
Get Curis Lifesciences corporate actions including splits, bonuses, and buybacks.
Check Curis Lifesciences stock events that may affect CURIS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -3.28% |
| 2025-12-04 | 2025-12-04 | Quarterly Result Announcement | NA | -9.29% |
Curis Lifesciences Competitors Screener - Peer Comparison
Screen CURIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,731 | 38.94 | 58,220 | 6.38% | 11,565 | 66.93 |
| Divis Laboratories | 179,284 | 69.71 | 10,560 | 8.73% | 2,520 | 55.02 |
| Torrent Pharmaceuticals | 152,449 | 71.45 | 13,886 | 20.34% | 2,138 | 55.98 |
| Cipla | 116,151 | 29.98 | 29,045 | 2.24% | 3,870 | 65.05 |
| Dr Reddys Laboratories | 110,874 | 26.13 | 33,593 | -0.44% | 3,998 | 64.53 |
| Zydus Life Science | 110,615 | 21.84 | 26,720 | 13.65% | 5,242 | 61.12 |
| Lupin | 108,210 | 20.12 | 27,488 | 19.98% | 5,345 | 63.99 |
| Mankind Pharma | 102,500 | 53.90 | 14,278 | 12.03% | 1,750 | 59.95 |
| Aurobindo Pharma | 88,898 | 25.46 | 33,385 | 3.21% | 3,376 | 63.83 |
| Laurus Labs | 78,506 | 89.85 | 6,868 | 22.01% | 890 | 65.69 |
Curis Lifesciences Company Announcements - News Screener
Screen CURIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.